Semler Scientific
Nicholas Faragasso has extensive experience in business development and sales across various medical and technological companies. Currently serving as AVP of Federal Accounts and Executive Director of Channel Development at Semler Scientific since October 2011, Nicholas has played a key role in promoting the QuantaFlo device, which conducts non-invasive physiological studies of peripheral arteries. Prior to this role, Nicholas was the Director of Business Development at Angelica Linen for a brief period in 2011 before downsizing. Previous positions include Territory Manager at Cardiva Medical, Account Executive at Inverness Medical, Territory Manager at CardioDynamics, VP of Sales at TotalTel, and Sales Manager at Worldcom. Nicholas holds a Bachelor's degree in English from Rutgers University and Thomas Edison State University.
This person is not in any offices
Semler Scientific
1 followers
Semler Scientific, Inc. is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. Semler Scientific's mission is to develop, manufacture and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA- cleared product in 2011, and received FDA 510(k) clearance for QuantaFlo®, the next generation version of this product, in 2015. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease. QuantaFlo® is used by Semler Scientific's customers to more comprehensively evaluate their patients for risk of heart attacks and strokes. Semler Scientific believes it is positioned to provide valuable information to its insurance company and physician customers, which in turn permits them to better guide patient care.